AARTIDRUGSPharmaceuticals
Aarti Drugs Ltd — Balance Sheet
₹319.75
-3.05%
Aarti Drugs Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 9.13 Cr | 9.19 Cr | 9.26 Cr | 9.26 Cr | — |
| Share Issued | 9.13 Cr | 9.19 Cr | 9.26 Cr | 9.26 Cr | — |
| Net Debt | 607.66 Cr | 555.67 Cr | 599.02 Cr | 516.73 Cr | — |
| Total Debt | 615.07 Cr | 564.28 Cr | 608.91 Cr | 542.82 Cr | — |
| Tangible Book Value | 1.36K Cr | 1.24K Cr | 1.17K Cr | 1.04K Cr | — |
| Invested Capital | 1.98K Cr | 1.84K Cr | 1.80K Cr | 1.57K Cr | — |
| Working Capital | 501.38 Cr | 525.18 Cr | 542.31 Cr | 453.31 Cr | — |
| Net Tangible Assets | 1.36K Cr | 1.24K Cr | 1.17K Cr | 1.04K Cr | — |
| Capital Lease Obligations | 2.83 Cr | 1.86 Cr | 2.40 Cr | 4.48 Cr | — |
| Common Stock Equity | 1.37K Cr | 1.28K Cr | 1.19K Cr | 1.04K Cr | — |
| Total Capitalization | 1.65K Cr | 1.56K Cr | 1.40K Cr | 1.17K Cr | — |
| Total Equity Gross Minority Interest | 1.37K Cr | 1.28K Cr | 1.19K Cr | 1.04K Cr | — |
| Minority Interest | 0.34 Cr | 0.41 Cr | 0.23 Cr | -0.06 Cr | — |
| Stockholders Equity | 1.37K Cr | 1.28K Cr | 1.19K Cr | 1.04K Cr | — |
| Other Equity Interest | 1.28K Cr | 1.19K Cr | 1.10K Cr | 943.76 Cr | — |
| Capital Stock | 91.27 Cr | 91.94 Cr | 92.60 Cr | 92.60 Cr | — |
| Common Stock | 91.27 Cr | 91.94 Cr | 92.60 Cr | 92.60 Cr | — |
| Total Liabilities Net Minority Interest | 1.21K Cr | 1.15K Cr | 1.23K Cr | 1.17K Cr | — |
| Total Non Current Liabilities Net Minority Interest | 368.37 Cr | 354.86 Cr | 279.25 Cr | 231.60 Cr | — |
| Other Non Current Liabilities | -43000.00 | -1000.00 | -33000.00 | -3000.00 | — |
| Non Current Deferred Taxes Liabilities | 78.23 Cr | 75.71 Cr | 70.97 Cr | 72.43 Cr | — |
| Long Term Debt And Capital Lease Obligation | 285.65 Cr | 276.24 Cr | 205.08 Cr | 140.38 Cr | — |
| Long Term Capital Lease Obligation | 1.65 Cr | 0.91 Cr | 0.40 Cr | 1.88 Cr | — |
| Long Term Debt | 284.00 Cr | 275.33 Cr | 204.68 Cr | 138.50 Cr | — |
| Long Term Provisions | 4.33 Cr | 2.74 Cr | 7.27 Cr | 9.23 Cr | — |
| Current Liabilities | 836.97 Cr | 795.54 Cr | 949.48 Cr | 940.06 Cr | — |
| Other Current Liabilities | 66.89 Cr | 2000.00 | 44.52 Cr | -43.50 Cr | — |
| Current Debt And Capital Lease Obligation | 329.42 Cr | 288.04 Cr | 403.83 Cr | 402.44 Cr | — |
| Current Capital Lease Obligation | 1.18 Cr | 0.95 Cr | 1.99 Cr | 2.60 Cr | — |
| Current Debt | 328.24 Cr | 287.09 Cr | 401.84 Cr | 399.84 Cr | — |
| Current Provisions | 4.29 Cr | 2.95 Cr | 4.37 Cr | 3.71 Cr | — |
| Payables | 416.14 Cr | 483.08 Cr | 529.84 Cr | 533.91 Cr | — |
| Total Tax Payable | 0.00 | 3.20 Cr | 7.32 Cr | 2.94 Cr | — |
| Accounts Payable | 416.14 Cr | 449.61 Cr | 492.53 Cr | 468.67 Cr | — |
| Total Assets | 2.57K Cr | 2.43K Cr | 2.42K Cr | 2.21K Cr | — |
| Total Non Current Assets | 1.24K Cr | 1.11K Cr | 929.60 Cr | 814.59 Cr | — |
| Other Non Current Assets | 17.62 Cr | 19.70 Cr | 23.67 Cr | 28.44 Cr | — |
| Investmentin Financial Assets | 22.41 Cr | 19.97 Cr | 18.80 Cr | 19.48 Cr | — |
| Goodwill And Other Intangible Assets | 7.15 Cr | 36.82 Cr | 24.33 Cr | 0.15 Cr | — |
| Other Intangible Assets | 7.15 Cr | 36.82 Cr | 24.33 Cr | 0.15 Cr | — |
| Net PPE | 1.19K Cr | 1.05K Cr | 885.92 Cr | 794.95 Cr | — |
| Gross PPE | 1.19K Cr | 1.63K Cr | 1.41K Cr | 1.27K Cr | — |
| Construction In Progress | 330.18 Cr | 244.03 Cr | 210.48 Cr | 105.17 Cr | — |
| Other Properties | 858.95 Cr | 1.75 Cr | 2.19 Cr | 4.09 Cr | — |
| Current Assets | 1.34K Cr | 1.32K Cr | 1.49K Cr | 1.39K Cr | — |
| Other Current Assets | 80.87 Cr | 109.27 Cr | 90.05 Cr | -1000.00 | — |
| Inventory | 472.93 Cr | 485.89 Cr | 516.29 Cr | 525.94 Cr | — |
| Other Receivables | 0.76 Cr | 7.74 Cr | 6.57 Cr | 24.76 Cr | — |
| Taxes Receivable | 10.00 Cr | 0.00 | 0.00 | — | — |
| Accounts Receivable | 751.18 Cr | 704.55 Cr | 864.84 Cr | 749.90 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 22.61 Cr | 8.93 Cr | 8.38 Cr | 21.61 Cr | — |
| Other Short Term Investments | 18.03 Cr | 2.19 Cr | 0.88 Cr | 12.64 Cr | — |
| Cash And Cash Equivalents | 4.58 Cr | 6.74 Cr | 7.50 Cr | 21.61 Cr | — |
| Retained Earnings | — | 1.16K Cr | 1.02K Cr | 878.75 Cr | 753.80 Cr |
| Additional Paid In Capital | — | 4.28 Cr | 3.62 Cr | 3.62 Cr | 3.02 Cr |
| Non Current Pension And Other Postretirement Benefit Plans | — | 2.74 Cr | 3.03 Cr | — | — |
| Non Current Deferred Revenue | — | 0.17 Cr | 0.17 Cr | 0.17 Cr | 0.17 Cr |
| Pensionand Other Post Retirement Benefit Plans Current | — | 2.95 Cr | 4.37 Cr | 3.71 Cr | 2.80 Cr |
| Other Payable | — | 29.77 Cr | 29.40 Cr | 61.57 Cr | 48.41 Cr |
| Dividends Payable | — | 0.50 Cr | 0.58 Cr | 0.72 Cr | 0.97 Cr |
| Non Current Prepaid Assets | — | 0.90 Cr | 0.56 Cr | 28.44 Cr | 7.26 Cr |
| Available For Sale Securities | — | 19.97 Cr | 18.80 Cr | 19.48 Cr | 17.30 Cr |
| Accumulated Depreciation | — | -574.60 Cr | -525.96 Cr | -479.06 Cr | -432.25 Cr |
| Machinery Furniture Equipment | — | 1.06K Cr | 912.19 Cr | 879.23 Cr | 838.29 Cr |
| Buildings And Improvements | — | 225.71 Cr | 193.24 Cr | 192.07 Cr | 188.22 Cr |
| Land And Improvements | — | 93.77 Cr | 93.77 Cr | 93.46 Cr | 64.98 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Restricted Cash | — | 0.50 Cr | 0.58 Cr | 0.72 Cr | 0.97 Cr |
| Prepaid Assets | — | 113.11 Cr | 95.13 Cr | 70.43 Cr | 53.58 Cr |
| Other Inventories | — | 5.19 Cr | 4.78 Cr | 5.62 Cr | 3.71 Cr |
| Finished Goods | — | 149.04 Cr | 126.53 Cr | 125.54 Cr | 89.49 Cr |
| Work In Process | — | 128.13 Cr | 172.82 Cr | 162.53 Cr | 112.42 Cr |
| Raw Materials | — | 203.53 Cr | 212.16 Cr | 232.25 Cr | 209.38 Cr |
| Allowance For Doubtful Accounts Receivable | — | -2.97 Cr | -3.96 Cr | -4.28 Cr | -3.49 Cr |
| Gross Accounts Receivable | — | 707.52 Cr | 868.80 Cr | 754.18 Cr | 558.72 Cr |
| Cash Financial | — | 6.74 Cr | 7.50 Cr | 20.33 Cr | 5.90 Cr |
| Tradeand Other Payables Non Current | — | — | 12.27 Cr | 9.39 Cr | 6.34 Cr |
| Cash Equivalents | — | — | 0.88 Cr | 1.28 Cr | 2.91 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Aarti Drugs Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.